We currently hold inventory in two different locations. If you purchase items from both locations, they will be shipped separately.
⠀⠀⠀⠀⠀⠀
QUICK SHIP delivery in 2-4 days
STANDARD ITEM delivery in 7- 14 days
⠀⠀⠀⠀⠀⠀
The location that your item ships from does not impact your shipping cost. You will pay exactly the same shipping fee regardless if you have Fast and/or Standard items in your cart.
⠀⠀⠀⠀⠀⠀
Description
Boiron Homéomunyl Influenzinum 9CH is a homeopathic medicinal product traditionally used in connection with flu-like conditions.
Each pack contains 4 single doses of Influenzinum 9CH. Influenzinum is prepared from the influenza vaccine strain selected for the current season and then subjected to homeopathic dilution and dynamization.
The 2026–2027 strain is intended for the current flu season.
This product is not a flu vaccine and should not be considered a substitute for vaccination or standard medical care.
Active Ingredient
Influenzinum 9CH
“9CH” refers to a homeopathic dilution prepared according to the Hahnemannian centesimal method.
Other Ingredients
- Lactose monohydrate
- Sucrose
Directions
The recommended dosage is:
- Take 1 single dose per week for 3 weeks, beginning at the start of autumn.
- Take the 4th dose one month after the 3rd dose.
Allow the entire contents of one single-dose container to dissolve slowly under the tongue.
Preferably take in the morning on an empty stomach or away from meals.
Precautions
Not recommended for children under 6 years of age.
Do not use if you are allergic to any of the ingredients.
Because this product contains lactose, it should not be used in cases of congenital galactosemia, glucose-galactose malabsorption syndrome, or lactase deficiency.
Because it contains sucrose, it should not be used in cases of fructose intolerance or sucrase-isomaltase deficiency.
Tell your doctor or pharmacist about any other medicines you are currently taking or have recently taken, including non-prescription products.
If you are pregnant or breastfeeding, consult a doctor or pharmacist before use.
Product Details
- Brand: Boiron
- Product: Homéomunyl Influenzinum 9CH
- Product Type: Homeopathic Medicinal Product
- Strength: 9CH
- Seasonal Strain: 2026–2027
- Age: 6 Years and Up
- Format: Single-Dose Granules
- Quantity: 4 Single Doses
- Country of Origin: France
- Made in: France
- EAN / CIP13: 3400935747532
PLEASE READ THE FOLLOWING FULL DISCLOSURE BEFORE PURCHASING OR TAKING THIS PRODUCT.
SUMMARY OF PRODUCT CHARACTERISTICS
ANSM – Updated: 09/15/2026
1. NAME OF THE MEDICINAL PRODUCT
Homéomunyl, granules in single-dose container.
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Influenzinum 9 CH ............................................................................................................ 0.01 mL
Per 1 g of granules in a single-dose container.
Excipients with known effect: lactose and sucrose.
For the full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Granules in a single-dose container.
4. CLINICAL PARTICULARS
4.1. Therapeutic indications
Homeopathic medicinal product traditionally used in the prevention of flu-like conditions.
4.2. Posology and method of administration
Medicinal product intended for adults and children over 6 years of age.
Dosage
From the beginning of autumn, take one dose per week for 3 weeks, then take the 4th dose one month after the 3rd dose.
Method of administration
Sublingual use.
Allow the entire contents of one single-dose container to dissolve under the tongue in the morning on an empty stomach, or preferably away from meals.
4.3. Contraindications
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Children under 6 years of age.
4.4. Special warnings and precautions for use
This medicinal product is not a vaccine.
Homeopathic treatment does not replace any specific treatment that may be required.
This medicinal product contains lactose. Its use is not recommended in patients with galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption syndrome.
This medicinal product contains sucrose. Its use is not recommended in patients with fructose intolerance, glucose-galactose malabsorption syndrome, or sucrase-isomaltase deficiency.
4.5. Interaction with other medicinal products and other forms of interaction
Not applicable.
4.6. Fertility, pregnancy and breastfeeding
Not applicable.
4.7. Effects on ability to drive and use machines
Not applicable.
4.8. Undesirable effects
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
Healthcare professionals should report any suspected adverse reactions through the national reporting system: French National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centers.
Website: https://signalement.social-sante.gouv.fr/
4.9. Overdose
Not applicable.
5. PHARMACOLOGICAL PROPERTIES
5.1. Pharmacodynamic properties
Pharmacotherapeutic class: Homeopathic medicinal product
In the absence of clinical trials, the indication for this medicinal product is based on its traditional homeopathic use.
5.2. Pharmacokinetic properties
Not applicable.
5.3. Preclinical safety data
Not applicable.
6. PHARMACEUTICAL PARTICULARS
6.1. List of excipients
Lactose and sucrose.
6.2. Incompatibilities
Not applicable.
6.3. Shelf life
12 months.
6.4. Special precautions for storage
No special storage precautions are required.
6.5. Nature and contents of container
Box of 4 single-dose containers (polypropylene/polyethylene), each containing 1 g.
6.6. Special precautions for disposal and other handling
Not applicable.
7. MARKETING AUTHORIZATION HOLDER
BOIRON
2 Avenue de l’Ouest Lyonnais
69510 Messimy
France
8. MARKETING AUTHORIZATION NUMBER(S)
34009 357 475 3 2: Granules in single-dose containers (PP/PE). Box of 4.
9. DATE OF FIRST AUTHORIZATION / RENEWAL OF THE AUTHORIZATION
[To be completed later by the marketing authorization holder]
10. DATE OF REVISION OF THE TEXT
[To be completed later by the marketing authorization holder]
11. DOSIMETRY
Not applicable.
12. INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS
Not applicable.
PRESCRIPTION AND DISPENSING CONDITIONS
Medicinal product not subject to medical prescription.
